Atlas Trials

Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH

Clinical trial NCT02915705 · COMPLETED

Trial details

NCT number
NCT02915705
Sponsor
Kyowa Kirin, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
X-Linked Hypophosphatemia
Start date
2016-09-08
Primary completion
2018-02-12
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.